CD44 and neoplasm: The CD44 splice variants are differentially expressed in both the normal and cancer cells, e.g., CD44v8-10 in pancreatic cancers [70] and CD44v6 in colorectal cancer including CSCs, which is a useful marker of tumor prognosis [71,72].